Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Endothelin receptor | Starlite/ChEMBL | References |
Homo sapiens | endothelin receptor type B | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus granulosus | pyroglutamylated rfamide peptide receptor | Endothelin receptor | 426 aa | 412 aa | 20.1 % |
Echinococcus multilocularis | pyroglutamylated rfamide peptide receptor | Endothelin receptor | 426 aa | 412 aa | 21.1 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Smad1 | 0.0092 | 0.0199 | 0.0199 |
Onchocerca volvulus | 0.0604 | 0.2698 | 0.5 | |
Leishmania major | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.013 | 0.0386 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.1639 | 0.7748 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.1639 | 0.7748 | 1 |
Brugia malayi | MH2 domain containing protein | 0.1344 | 0.6308 | 0.6308 |
Brugia malayi | hypothetical protein | 0.0604 | 0.2698 | 0.2698 |
Trypanosoma brucei | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.013 | 0.0386 | 1 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.013 | 0.0386 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.2101 | 1 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.1639 | 0.7748 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.2101 | 1 | 1 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.013 | 0.0386 | 1 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.013 | 0.0386 | 0.0247 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.1344 | 0.6308 | 0.6308 |
Brugia malayi | TAR-binding protein | 0.1639 | 0.7748 | 0.7748 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.013 | 0.0386 | 0.0247 |
Loa Loa (eye worm) | MH1 domain-containing protein | 0.0092 | 0.0199 | 0.0199 |
Loa Loa (eye worm) | hypothetical protein | 0.2101 | 1 | 1 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0665 | 0.2995 | 0.3703 |
Schistosoma mansoni | hypothetical protein | 0.0665 | 0.2995 | 0.3703 |
Loa Loa (eye worm) | Smad1 | 0.0092 | 0.0199 | 0.0199 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.1344 | 0.6308 | 0.6308 |
Echinococcus multilocularis | GPCR, family 2 | 0.0665 | 0.2995 | 0.3703 |
Brugia malayi | isocitrate dehydrogenase | 0.013 | 0.0386 | 0.0386 |
Schistosoma mansoni | hypothetical protein | 0.1436 | 0.6758 | 0.8688 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.013 | 0.0386 | 0.0247 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0665 | 0.2995 | 0.2995 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0665 | 0.2995 | 0.3703 |
Schistosoma mansoni | hypothetical protein | 0.0665 | 0.2995 | 0.3703 |
Brugia malayi | RNA binding protein | 0.1639 | 0.7748 | 0.7748 |
Trypanosoma cruzi | isocitrate dehydrogenase, putative | 0.013 | 0.0386 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.1639 | 0.7748 | 1 |
Plasmodium vivax | isocitrate dehydrogenase [NADP], mitochondrial, putative | 0.013 | 0.0386 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0092 | 0.0199 | 0.0199 |
Brugia malayi | MH1 domain containing protein | 0.0092 | 0.0199 | 0.0199 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.013 | 0.0386 | 0.5 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0665 | 0.2995 | 0.2995 |
Schistosoma mansoni | tar DNA-binding protein | 0.1639 | 0.7748 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0665 | 0.2995 | 0.3703 |
Trypanosoma brucei | isocitrate dehydrogenase, putative | 0.013 | 0.0386 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.1436 | 0.6758 | 0.6758 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.013 | 0.0386 | 0.0247 |
Schistosoma mansoni | tar DNA-binding protein | 0.1639 | 0.7748 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.1639 | 0.7748 | 0.7748 |
Brugia malayi | Isocitrate dehydrogenase | 0.013 | 0.0386 | 0.0386 |
Loa Loa (eye worm) | hypothetical protein | 0.1436 | 0.6758 | 0.6758 |
Schistosoma mansoni | tar DNA-binding protein | 0.1639 | 0.7748 | 1 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0665 | 0.2995 | 0.3703 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0665 | 0.2995 | 0.3703 |
Loa Loa (eye worm) | hypothetical protein | 0.0604 | 0.2698 | 0.2698 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0665 | 0.2995 | 0.2995 |
Brugia malayi | MH2 domain containing protein | 0.0092 | 0.0199 | 0.0199 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.013 | 0.0386 | 0.0247 |
Echinococcus granulosus | GPCR family 2 | 0.0665 | 0.2995 | 0.3703 |
Loa Loa (eye worm) | RNA binding protein | 0.1639 | 0.7748 | 0.7748 |
Loa Loa (eye worm) | hypothetical protein | 0.0665 | 0.2995 | 0.2995 |
Brugia malayi | MH2 domain containing protein | 0.0092 | 0.0199 | 0.0199 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.1639 | 0.7748 | 0.7748 |
Plasmodium falciparum | isocitrate dehydrogenase [NADP], mitochondrial | 0.013 | 0.0386 | 1 |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.013 | 0.0386 | 0.0386 |
Brugia malayi | MH1 domain containing protein | 0.0092 | 0.0199 | 0.0199 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.013 | 0.0386 | 0.0247 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.013 | 0.0386 | 0.0247 |
Schistosoma mansoni | hypothetical protein | 0.0665 | 0.2995 | 0.3703 |
Brugia malayi | RNA recognition motif domain containing protein | 0.1639 | 0.7748 | 0.7748 |
Trypanosoma cruzi | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.013 | 0.0386 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ABC (functional) | = 200 mmHg hr-1 | In vivo area between curve (ABC) as calculated from the blood pressure recordings before and after administration of 30 mg/kg of the compound to hypertensiveDahl salt sensitive rats; number of rats=12 | ChEMBL. | 15139756 |
Duration of action (functional) | = 18 hr | Duration of action of compound for reducing the blood pressure of rats was determined | ChEMBL. | 15139756 |
IC50 (functional) | = 16.9 nM | Antagonist activity towards human recombinant Endothelin A receptor expressed in chinese hamster ovary (CHO) cells determined using [125I]-ET-1 as radioligand | ChEMBL. | 15139756 |
IC50 (functional) | = 16.9 nM | Antagonist activity towards human recombinant Endothelin A receptor expressed in chinese hamster ovary (CHO) cells determined using [125I]-ET-1 as radioligand | ChEMBL. | 15139756 |
IC50 (functional) | = 25 nM | Antagonist activity towards human recombinant Endothelin B receptor expressed in chinese hamster ovary (CHO) cells determined using [125I]-ET-1 as radioligand | ChEMBL. | 15139756 |
IC50 (functional) | = 25 nM | Antagonist activity towards human recombinant Endothelin B receptor expressed in chinese hamster ovary (CHO) cells determined using [125I]-ET-1 as radioligand | ChEMBL. | 15139756 |
Kd (functional) | = 7.37 | Inhibitory potency at native endothelin A and B receptors by inhibiting sarafotoxin Sf6 contractions of rat tracheal rings | ChEMBL. | 15139756 |
Kd (functional) | = 8.98 | Inhibitory potency of the compound at native endothelin A and endothelin B receptors by inhibiting endothelin-1 contractions of rat aortic rings | ChEMBL. | 15139756 |
Max effect (functional) | = -15 mmHg | Maximum effect of the compound on reduciton of mean arterial blood pressure was determined in rats | ChEMBL. | 15139756 |
pA2 (functional) | = 7.37 | Inhibitory potency at native endothelin A and B receptors by inhibiting sarafotoxin Sf6 contractions of rat tracheal rings | ChEMBL. | 15139756 |
pA2 (functional) | = 8.98 | Inhibitory potency of the compound at native endothelin A and endothelin B receptors by inhibiting endothelin-1 contractions of rat aortic rings | ChEMBL. | 15139756 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.